UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, DC 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934

Date of Report (Date of earliest event reported) June 1, 2007

Velcera, Inc.

(Exact Name of registrant as specified in its charter)

Delaware	000-51622	20-3327015
(State or other jurisdiction	(Commission	(IRS Employer
of incorporation)	File Number)	Identification No.)

201 Corporate Drive

Langhorne, Pennsylvania 19047-8007

(Address of Principal Executive Offices) (Zip Code)

(215) 579-7200

(Registrant’s telephone number, including area code)

(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

[ ] Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

[ ] Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

[ ] Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

[ ] Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Item 1.01. Entry into a Material Definitive Agreement.

On June 1, 2007, Velcera, Inc. (the “Company” or “Velcera”) entered into an exclusive License and Development Agreement (the “Agreement”) with Novartis Animal Health, Inc. (“Novartis”). Pursuant to the parties’ Agreement, Velcera granted to Novartis a royalty-bearing worldwide exclusive right to develop and commercialize a single undisclosed product utilizing the Company’s licensed Promist™ oral spray technology for pets. Velcera will receive an upfront license fee, license fees associated with certain milestones and royalties on sales of the product.

ITEM 9.01. FINANCIAL STATEMENTS AND EXHIBITS.

(d) Exhibits.

Exhibit No.

Description

99.1	Press release dated June 7, 2007

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.


	VELCERA, INC.

Date: June 7, 2007	By:	/s/ Matthew C. Hill
		Mathew C. Hill
		Chief Financial Officer

VELCERA, INC. 8-K